Elsevier Inc.

SHERPA: Unknown

People

  1. Morris
    Morris
  2. Danila
    Danila
  3. McHugh
    McHugh
  4. Rathkopf
    Rathkopf
  5. Scher
    Scher
  6. Slovin
    Slovin
  7. Autio
    Autio
  8. Bajorin
    Bajorin
  9. Chan
    Chan
  10. Farooki
    Farooki

Groups

  1. Department of Medicine (4)
  2. Genitourinary Oncology Service (4)
  3. Solid Tumor Oncology Division (4)
  4. Hematologic Malignancies, Division of (2)
  5. Survivorship Research (2)
  6. Biostatistics Service (1)
  7. Division of Subspecialty Medicine (1)
  8. Endocrinology (1)
  9. Epidemiology and Biostatistics (1)
  10. Molecular Imaging and Therapy Service (1)
Search Within
  1. "Clinical Genitourinary Cancer"
  2. "Dana Rathkopf"
Formats
  1. Journal Article (4)
Groups
  1. Department of Medicine (4)
  2. Genitourinary Oncology Service (4)
  3. Solid Tumor Oncology Division (4)
  4. Hematologic Malignancies, Division of (2)
  5. Survivorship Research (2)
  6. Biostatistics Service (1)

More Groups

People
  1. Dana Rathkopf (4)
  2. Michael Morris (4)
  3. Daniel Danila (2)
  4. Deaglan McHugh (2)
  5. Howard Scher (2)
  6. Susan Slovin (2)

More People

Years
  1. 2021 (2)
  2. 2020 (1)
  3. 2015 (1)
Publications
  1. Clinical Genitourinary Cancer (4)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II, nonrandomized open trial assessing pain efficacy with radium-223 in symptomatic metastatic castration-resistant prostate cancer
    Journal Article

    McHugh, D.; Tagawa, S.; Moryl, N.; Milowsky, M.; Heller, G.; Osborne, J.; Rathkopf, D.; Basch, E.; Pandit-Taskar, N.; Morris, M. J.
    Clinical Genitourinary Cancer (2021)

    Fulltext@MSK | Save
  • Genitourinary medical oncology expert opinion survey regarding treatment management in the COVID-19 pandemic
    Journal Article

    Sarfaty, M.; Feldman, D. R.; Morris, M. J.; Motzer, R. J.; Rathkopf, D. E.; Regazzi, A. M.; Iyer, G.; Voss, M. H.; Bajorin, D. F.; Rosenberg, J. E.
    Clinical Genitourinary Cancer (2021)

    Fulltext@MSK | Save
  • A phase I trial of IGF-1R inhibitor cixutumumab and mTOR inhibitor temsirolimus in metastatic castration-resistant prostate cancer
    Journal Article

    McHugh, D. J.; Chudow, J.; DeNunzio, M.; Slovin, S. F.; Danila, D. C.; Morris, M. J.; Scher, H. I.; Rathkopf, D. E.
    Clinical Genitourinary Cancer (2020)

    Fulltext@MSK | Save
  • Severe hypocalcemia associated with denosumab in metastatic castration-resistant prostate cancer: Risk factors and precautions for treating physicians
    Journal Article

    Autio, K. A.; Farooki, A.; Glezerman, I. G.; Chan, A.; Schneider, C. W.; Barr, H. C.; Seyboth, B. M.; Kampel, L. J.; Danila, D. C.; Rathkopf, D. E.; more...
    Clinical Genitourinary Cancer (2015)

    Fulltext@MSK | Save